核纤层蛋白与心脏
LMNA基因编码核纤层蛋白A/C,其突变导致常染色体显性遗传性严重心脏病,占扩张型心肌病(DCM)的10%。该病以进行性传导系统疾病、心律失常和收缩功能受损为特征,即使左心室功能轻度受损,事件发生率也高,比其他常见DCM更具恶性。识别该病很重要,因为需要早期植入ICD,且针对MAPK通路的口服药物和个性化治疗有望实现。
要点
- LMNA突变占DCM的10%,常表现为早发传导疾病和心律失常。
- 即使左室功能轻度受损,室性心律失常事件风险高,需早期考虑ICD。
- 基因分型和家系筛查对确认或排除LMNA突变具有临床重要性。
核心结论
- LMNA突变导致高恶性度的DCM,需早期植入ICD,并有望实现个性化治疗。
研究设计与样本
- 综述,总结LMNA心脏病的遗传学、临床表现、筛查和管理。
主要发现
- LMNA突变占DCM的10%,以进行性传导系统疾病、心律失常和收缩功能受损为特征。
- 即使左心室功能轻度受损,事件发生率仍高,比其他常见DCM更具恶性。
- 某些临床场景(如家族性DCM伴早期传导疾病)中,LMNA突变预检概率可能较高。
关键数值与推荐
- LMNA突变占DCM的10%。
临床怎么用
- 识别LMNA心脏病以早期植入ICD。
- 基因分型和家系筛查用于确认或排除LMNA突变。
- 整合遗传信息、心肌细胞力学功能和核膜病理数据以优化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lamins A and C are intermediate filament nuclear envelope proteins encoded by the LMNA gene. Mutations in LMNA cause autosomal dominant severe heart disease, accounting for 10% of dilated cardiomyopathy (DCM). Characterised by progressive conduction system disease, arrhythmia and systolic impairment, lamin A/C heart disease is more malignant than other common DCMs due to high event rates even when the left ventricular impairment is mild. It has several phenotypic mimics, but overall it is likely to be an under-recognised cause of DCM. In certain clinical scenarios, particularly familial DCM with early conduction disease, the pretest probability of finding an LMNA mutation may be quite high.Recognising lamin A/C heart disease is important because implantable cardioverter defibrillators need to be implanted early. Promising oral drug therapies are within reach thanks to research into the mitogen-activated protein kinase (MAPK) and affiliated pathways. Personalised heart failure therapy may soon become feasible for LMNA, alongside personalised risk stratification, as variant-related differences in phenotype severity and clinical course are being steadily elucidated.Genotyping and family screening are clinically important both to confirm and to exclude LMNA mutations, but it is the three-pronged integration of such genetic information with functional data from in vivo cardiomyocyte mechanics, and pathological data from microscopy of the nuclear envelope, that is properly reshaping our LMNA knowledge base, one variant at a time. This review explains the biology of lamin A/C heart disease (genetics, structure and function of lamins), clinical presentation (diagnostic pointers, electrocardiographic and imaging features), aspects of screening and management, including current uncertainties, and future directions.
引用
- Captur G, Arbustini E, Bonne G, et al. Lamin and the heart. Heart. 2017. PMID: 29175975. doi:10.1136/heartjnl-2017-312338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。